NasdaqGS:LIVNMedical Equipment
The Bull Case for LivaNova (LIVN) Could Change Following Essenz Perfusion Launch in China—Learn Why
LivaNova PLC has launched the Essenz Perfusion System commercially in China after securing regulatory approval from the National Medical Products Administration, expanding access to advanced heart-lung machine technology in the world’s second-largest market for these devices.
This rollout enables more than 700 Chinese hospitals to utilize patient-tailored, data-driven perfusion technology, advancing clinical standards for over 185,000 projected extracorporeal circulation procedures in...